[go: up one dir, main page]

MA23587A1 - TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME - Google Patents

TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME

Info

Publication number
MA23587A1
MA23587A1 MA23930A MA23930A MA23587A1 MA 23587 A1 MA23587 A1 MA 23587A1 MA 23930 A MA23930 A MA 23930A MA 23930 A MA23930 A MA 23930A MA 23587 A1 MA23587 A1 MA 23587A1
Authority
MA
Morocco
Prior art keywords
nicotine
smoking
treatment
need
related syndrome
Prior art date
Application number
MA23930A
Other languages
French (fr)
Inventor
Majeti Satyanarayama
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MA23587A1 publication Critical patent/MA23587A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA23930A 1994-06-23 1995-05-16 TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME MA23587A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26455494A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
MA23587A1 true MA23587A1 (en) 1995-12-31

Family

ID=23006582

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23930A MA23587A1 (en) 1994-06-23 1995-05-16 TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME

Country Status (6)

Country Link
AU (1) AU2770895A (en)
IL (1) IL114128A0 (en)
MA (1) MA23587A1 (en)
PE (1) PE41096A1 (en)
WO (1) WO1996000070A1 (en)
ZA (1) ZA955031B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0828489A4 (en) * 1996-03-13 2001-04-04 Univ Yale TREATMENTS FOR QUITTING SMOKING INVOLVING THE USE OF NALTREXONE AND RELATED COMPOUNDS
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
EP0906089B1 (en) * 1996-05-13 2003-08-27 Novartis Consumer Health S.A. Buccal delivery system
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
US6165516A (en) * 1996-11-27 2000-12-26 Wm. Wrigley Jr. Company Method of controlling release of caffeine in chewing gum
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
AU784112B2 (en) 1999-04-06 2006-02-09 Wm. Wrigley Jr. Company Pharmaceutical chewing gum formulations
US7115288B2 (en) 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
DE20018196U1 (en) 2000-10-25 2001-01-11 Peter, Michael N., 22297 Hamburg Confectionery product for smoking cessation
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
JP2007516149A (en) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ， インコーポレイテッド Method for controlling uniformity of substrate temperature, built-in heating unit and chemical supply unit using the same
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
WO2005046363A2 (en) 2003-11-07 2005-05-26 U.S. Smokeless Tobacco Company Tobacco compositions
US8627828B2 (en) * 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (en) 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heating unit
ES2594867T3 (en) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
EP2654738B1 (en) * 2010-12-21 2018-04-18 Fertin Pharma A/S Chewing gum composition comprising cross-linked polyacrylic acid
KR102852740B1 (en) 2018-02-02 2025-08-29 알렉스자 파마스티칼즈, 인크. Electrical Condensation Aerosol Device
CA3173292A1 (en) * 2020-09-03 2022-03-10 Walid Abi Aoun Aerosol-generating material for oral caffeine delivery
CN115590855A (en) * 2022-10-26 2023-01-13 江南大学（Cn） A method for reducing nicotine content in nicotine products

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617418C3 (en) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Manufacture of solid drug forms with delayed release of active ingredients
DE1901277A1 (en) * 1969-01-10 1970-08-06 Partipharm Ag Chewing gum to com ensate for excessive - cigarette smoking
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (en) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg DEVICE FOR THE DEWNING OF EATING, DRINKING, SMOKING AND / OR ADDICTIVE Habits
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
DK365389D0 (en) * 1989-07-24 1989-07-24 Fertin Lab As ANTIFUNGAL CHEMICAL GUM PREPARATION
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
FI913526L (en) * 1990-08-23 1992-02-24 Wrigley W M Jun Co CHEWING GUM WITH MOISTURE CONTAINER.

Also Published As

Publication number Publication date
PE41096A1 (en) 1996-10-08
ZA955031B (en) 1996-02-08
AU2770895A (en) 1996-01-19
WO1996000070A1 (en) 1996-01-04
IL114128A0 (en) 1995-10-31

Similar Documents

Publication Publication Date Title
MA23587A1 (en) TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
MA23588A1 (en) TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
DE69619433D1 (en) Tobacco smoke filters and methods of making the same
FI972781L (en) Methods and compositions for treating allergic rhinitis and other diseases using decarboethoxyloratadiene
EP0925046A4 (en) TOPICAL FORMULATIONS AND METHODS FOR THE TREATMENT OF HEMORROIDAL PAIN
FI971969A0 (en) Compositions and method of use for the treatment of hemorrhoids
FI935827L (en) Method and device for wet cleaning of gases
FI950587A7 (en) Methods useful in the prevention and treatment of endotoxin poisoning
PT836390E (en) CIGARETTE AND METHOD FOR THE MANUFACTURE OF CIGARETTE FOR ELECTRICAL SYSTEM OF SMOKING
EP0776210A4 (en) METHOD FOR PROPHYLAXIS AND / OR TREATMENT OF PROLIFERATIVE AND / OR INFLAMMATORY CONDITIONS OF THE SKIN
FR2726191B1 (en) DEVICE FOR THE TREATMENT OF APNEA SYNDROME DURING SLEEP
DE69003977D1 (en) Method and device for determining the stem content of tobacco.
MA23586A1 (en) TREATMENT OF NEEDS FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
EE9800234A (en) Method of treatment and pharmaceutical composition
ATE201992T1 (en) CARBOSTYRIL DERIVATIVE FOR THE TREATMENT OF OPHTHALMOLOGICAL DISEASES
FI971750A0 (en) Compositions for the treatment of multiple sclerosis and its treatment
NO951175D0 (en) Cigarette filter and process for its manufacture
FI951060L (en) Formulations and treatment methods
DE69306328D1 (en) Device for automatic smoking of tobacco rolls and for analyzing the smoke
BR9001661A (en) SMOKING AND TOBACCO TREATMENT ARTICLE
EP0750620A4 (en) CARBAPENEMIC COMPOUNDS, COMPOSITIONS CONTAINING SAME, AND METHODS OF TREATMENT THEREOF
ITMI931359A1 (en) PROCEDURE AND DEVICE FOR DRYING TOBACCO
BR9507375A (en) Treatment of particulate surfaces
EP1021445A4 (en) ANTIBACTERIAL CARBAPENEM COMPOSITIONS, PREPARATIONS CONTAINING SAME, AND METHODS OF TREATMENT
BR8904742A (en) CIGARETTES AND ALTERNATIVE FILTERS